Literature DB >> 23960652

Assessment of cardiac involvement of hepatitis C virus; tissue Doppler imaging and NTproBNP study.

Ahmed Saleh1, Akira Matsumori, Hany Negm, Hany Fouad, Ahmed Onsy, Mohammed Shalaby, Enas Hamdy.   

Abstract

INTRODUCTION: Hepatitis C disease burden is substantially increasing in Egyptian community, it is estimated that prevalence of Hepatitis C virus (HCV) in Egyptian community reach 22% of total population. Recently there is a global alert of HCV cardiovascular complications.
OBJECTIVE: To evaluate LV diastolic functions of HCV patients using tissue Doppler Imaging and NTPBNP.
METHODS: 30 HCV patients of 30 years, sex & BMI matched controls were evaluated by PCR, ECG, Echocardiography "conventional Doppler, pulsed wave tissue Doppler (PW-TD), strain rate imaging" & NTPBNP to assess LV diastolic functions. Mean age was 32.8 years ± 5.1 in HCV group, 29.8 years ± 6.6 in control group. Cardiovascular anomalies and predisposing factors were excluded.
RESULTS: HCV group has shown significant increase in QTc interval, significant statistical increase in A wave, deceleration time; (p < 0.05), highly significant decrease in tissue Doppler E a (p < 0.001), highly significant decrease in A a (p < 0.001), highly significant increased E/E a ratio (p value < 0.001), significant decrease in E a/A a ratio and significant increase in SRa (p < 0.05). NTPBNP levels showed highly significant increase with mean value 222 pg/ml ± 283 in HCV group and 32.7 pg/ml ± 21.2 in control group (p value < 0.001). The best cut-off value of NTPBNP to detect diastolic dysfunction in HCV group was 213 pg/ml. No statistical differences in SRe/SRa and E/SRe ratios were observed, however they had significant correlation with NTPBNP level and tissue Doppler parameters. The best cut-off value of E/SRe ratio to detect diastolic dysfunction in HCV group was 0.91, with 75% sensitivity and 100% specificity. CONCLUSION AND RECOMMENDATION: This data show the first direct evidence that HCV infection causes diastolic dysfunction without any other predisposing factors, probably due to chronic inflammatory reaction with mild fibrosis in the heart. Previous studies did not follow strict inclusion and exclusion criteria that confirm the independent role of HCV to cause diastolic dysfunction. Tissue Doppler was more sensitive to diagnose diastolic dysfunction than conventional Doppler.

Entities:  

Keywords:  Cardiomyopathy; Diastolic dysfunction; Hepatitis C virus; NTproBNP; Strain rate imaging; Tissue Doppler imaging

Year:  2011        PMID: 23960652      PMCID: PMC3727462          DOI: 10.1016/j.jsha.2011.04.005

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  10 in total

1.  Clinical criteria and biochemical markers for the detection of systolic dysfunction.

Authors:  K Yamamoto; J C Burnett; E A Bermudez; M Jougasaki; K R Bailey; M M Redfield
Journal:  J Card Fail       Date:  2000-09       Impact factor: 5.712

Review 2.  ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  Sharon Ann Hunt
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

3.  Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Klio Papadopoulou; Haralambos Karvounis; Hara Dimitroula; Georgios Koliakos; Theodoros Karamitsos; Despoina Parcharidou; Loukas Settas
Journal:  J Rheumatol       Date:  2010-03-01       Impact factor: 4.666

4.  Myocarditis and heart failure associated with hepatitis C virus infection.

Authors:  Akira Matsumori; Toshio Shimada; Nora M Chapman; Steven M Tracy; Jay W Mason
Journal:  J Card Fail       Date:  2006-05       Impact factor: 5.712

5.  Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections.

Authors:  Sylvie Deuffic-Burban; Mostafa K Mohamed; Bernard Larouze; Fabrice Carrat; Alain-Jacques Valleron
Journal:  J Hepatol       Date:  2005-09-15       Impact factor: 25.083

6.  High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C.

Authors:  A Antonelli; C Ferri; S M Ferrari; M Colaci; M Sebastiani; A L Zignego; E Ghiri; F Goglia; P Fallahi
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

7.  Direct comparison of B-type natriuretic peptide and N-terminal pro-BNP for assessment of cardiac function in a large population of symptomatic patients.

Authors:  Hun-Jun Park; Sang Hong Baek; Sung Won Jang; Dong-Bin Kim; Dong Il Shin; Woo-Seung Shin; Pum Joon Kim; Hae-Bin Jung; Hae-Ok Jung; Ki-Bae Seung; Kyu Bo Choi
Journal:  Int J Cardiol       Date:  2009-01-15       Impact factor: 4.164

Review 8.  Cardiac and systemic haemodynamic complications of liver cirrhosis.

Authors:  Jens H Henriksen; Søren Møller
Journal:  Scand Cardiovasc J       Date:  2009-08       Impact factor: 1.589

9.  Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.

Authors:  Angelika Hammerer-Lercher; Wilma Ludwig; Gerda Falkensammer; Silvana Müller; Elke Neubauer; Bernd Puschendorf; Otmar Pachinger; Johannes Mair
Journal:  Clin Chem       Date:  2004-05-13       Impact factor: 8.327

10.  Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease.

Authors:  Tanja M Raedle-Hurst; Christoph Welsch; Nicole Forestier; Bernd Kronenberger; Georg Hess; Eva Herrmann; Stefan Zeuzem; Jochen Raedle
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-09       Impact factor: 2.566

  10 in total
  6 in total

1.  Cardiovascular risk assessment by electrocardiographic Holter monitoring in patients with chronic hepatitis C.

Authors:  Adam R Poliwczak; Jolanta Białkowska; Joanna Woźny; Marzena Koziróg; Agnieszka Bała; Maciej Jabłkowski
Journal:  Arch Med Sci       Date:  2020-07-15       Impact factor: 3.318

Review 2.  Dilated cardiomyopathy update: infectious-immune theory revisited.

Authors:  Chuichi Kawai; Akira Matsumori
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

3.  Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.

Authors:  Phillip J Ngu; Michelle Butler; Alan Pham; Stuart K Roberts; Andrew J Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2015-12-15       Impact factor: 2.357

4.  Cardiac dysfunction in liver cirrhosis: A tissue Doppler imaging study from Egypt.

Authors:  Fatma Mohammad Nasr; Amna Metwaly; Ashraf Abdel Khalik; Hesham Darwish
Journal:  Electron Physician       Date:  2015-08-10

Review 5.  Dilated cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; DeLisa Fairweather; Alida L P Caforio; Felicitas Escher; Ray E Hershberger; Steven E Lipshultz; Peter P Liu; Akira Matsumori; Andrea Mazzanti; John McMurray; Silvia G Priori
Journal:  Nat Rev Dis Primers       Date:  2019-05-09       Impact factor: 65.038

6.  Myocardial involvement in coronavirus disease 19.

Authors:  Ahmed Saleh; Akira Matsumori; Sherif Abdelrazek; Sara Eltaweel; Amjad Salous; Franz-Josef Neumann; Matthias Antz
Journal:  Herz       Date:  2020-11-20       Impact factor: 1.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.